Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Yi Min Liu, Wei Chun HuangFu, Han Li Huang, Wei Cheng Wu, Yi Lin Chen, Yun Yen, Hsiang Ling Huang, Chih Ying Nien, Mei Jung Lai, Shiow Lin Pan, Jing Ping Liou

研究成果: 雜誌貢獻評論/辯論同行評審

摘要

The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

原文英語
文章編號112633
期刊European Journal of Medicinal Chemistry
202
DOIs
出版狀態已發佈 - 九月 15 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

指紋 深入研究「Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)」主題。共同形成了獨特的指紋。

引用此